Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) shares traded up 0.5% during mid-day trading on Friday . The stock traded as high as €41.80 ($44.95) and last traded at €41.80 ($44.95). 100 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 1,927 shares. The stock had previously closed at €41.60 ($44.73).
Biotest Aktiengesellschaft Stock Performance
The company has a debt-to-equity ratio of 151.29, a current ratio of 5.00 and a quick ratio of 1.66. The company has a 50 day simple moving average of €42.04 and a 200-day simple moving average of €42.28. The stock has a market capitalization of $827.22 million, a P/E ratio of 18.25 and a beta of 0.27.
Biotest Aktiengesellschaft Company Profile
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Read More
- Five stocks we like better than Biotest Aktiengesellschaft
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 4/29 – 5/3
- Consumer Staples Stocks, Explained
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Are Penny Stocks a Good Fit for Your Portfolio?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
